UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project

Haematologica (Roma), 2018-07, Vol.103 (7), p.1191

2018

Volltextzugriff (PDF)

Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia

Cell chemical biology, 2018-07, Vol.25 (7), p.891-905.e8

2018

Volltextzugriff (PDF)

RNF5, DAB2 and Friends: Novel Drug Targets for Cystic Fibrosis

Current pharmaceutical design, 2017-01, Vol.23 (1), p.176

2017

Volltextzugriff (PDF)

Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas

American journal of hematology, 2020-02, Vol.95 (2), p.151-155

2020

Volltextzugriff (PDF)

The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs

International journal of molecular sciences, 2022-03, Vol.23 (6), p.3175

2022

Volltextzugriff (PDF)

Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6576

2023

Volltextzugriff (PDF)

High-Content Screening Identifies Vanilloids as a Novel Class of Inhibitors of NET Formation

Frontiers in immunology, 2019-04, Vol.10, p.963-963

2019

Volltextzugriff (PDF)

Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12274

2022

Volltextzugriff (PDF)

Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation

Scientific reports, 2015-07, Vol.5 (1), p.12138, Article 12138

2015

Volltextzugriff (PDF)

GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease

International journal of molecular sciences, 2020-06, Vol.21 (12), p.4486

2020

Volltextzugriff (PDF)

Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR Modulators

Pharmaceuticals (Basel, Switzerland), 2021-12, Vol.14 (12), p.1296

2021

Volltextzugriff (PDF)

Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta

JCI insight, 2020-08, Vol.5 (16)

2020

Volltextzugriff (PDF)

Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays

Pharmaceuticals (Basel, Switzerland), 2022-02, Vol.15 (3), p.274

2022

Volltextzugriff (PDF)

The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism

Frontiers in pharmacology, 2018-12, Vol.9, p.1464-1464

2018

Volltextzugriff (PDF)

Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3848-3853

2012

Volltextzugriff (PDF)

Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study

British journal of haematology, 2015-02, Vol.168 (3), p.455-459

2015

Volltextzugriff (PDF)

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi

Frontiers in oncology, 2021-12, Vol.11, p.789891-789891

2021

Volltextzugriff (PDF)

Long-Term Follow-Up Analysis of HD9601 Trial Comparing ABVD Versus Stanford V Versus MOPP/EBV/CAD in Patients With Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study From the Intergruppo Italiano Linfomi

Journal of clinical oncology, 2011-11, Vol.29 (32), p.4227-4233

2011

Volltextzugriff (PDF)

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study

Haematologica (Roma), 2016-04, Vol.101 (4), p.e139

2016

Volltextzugriff (PDF)

Synthesis and biological evaluation of thiazole derivatives on basic defects underlying cystic fibrosis

Bioorganic & medicinal chemistry letters, 2020-11, Vol.30 (21), p.127473-127473, Article 127473

2020

Volltextzugriff (PDF)

Changing the Microstructural and Chemical Properties of Graphene Oxide Through a Chemical Route

Applied spectroscopy, 2022-12, Vol.76 (12), p.1452-1464

2022

Volltextzugriff (PDF)

Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del‐CFTR

ChemMedChem, 2024-02, Vol.19 (4), p.e202300391-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project

Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia

RNF5, DAB2 and Friends: Novel Drug Targets for Cystic Fibrosis

Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas

The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs

Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators

High-Content Screening Identifies Vanilloids as a Novel Class of Inhibitors of NET Formation

Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing

Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation

GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease

Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR Modulators

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B‐cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta

Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays

The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism

Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database

Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study

Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi

Chromosome 2p gain in monoclonal B‐cell lymphocytosis and in early stage chronic lymphocytic leukemia

Long-Term Follow-Up Analysis of HD9601 Trial Comparing ABVD Versus Stanford V Versus MOPP/EBV/CAD in Patients With Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study From the Intergruppo Italiano Linfomi

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study

Synthesis and biological evaluation of thiazole derivatives on basic defects underlying cystic fibrosis

Changing the Microstructural and Chemical Properties of Graphene Oxide Through a Chemical Route

Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del‐CFTR

Suchergebnisse filtern